INTUITIVE SURGICAL INCISRG
INTUITIVE SURGICAL INC Financial Overview 2021–2025
Intuitive Surgical continues to aggressively widen its moat, evidenced by the rapid deployment of 870 next-generation da Vinci 5 systems and a 51% surge in Ion procedures during FY2025. This acceleration confirms the company’s ability to layer new platforms onto its core robotic monopoly, transforming capital placements into a predictable, high-margin recurring revenue stream. The financial trajectory reflects this compounding power: total revenue nearly doubled from $5.7 billion in FY2021 to $10.1 billion in FY2025.
The "razor-and-blade" economics remain the central investment driver. Global da Vinci procedure volumes grew 18% to 3.15 million in FY2025, directly propelling a 19% increase in instruments and accessories revenue to $6.02 billion. While the active installed base expanded 12% to over 11,100 systems, the transition to newer hardware pressured product gross margins, which dipped to 66.0% from 67.5% the prior year due to tariffs and manufacturing ramp-up costs. Despite margin compression, the company ended the year with $9.03 billion in cash and investments. The market continues to award this growth a significant premium, with the stock trading at 72.0x earnings and a $201.1 billion market cap at the close of FY2025.
Recent Developments (Q3 and Q4 2025)
Intuitive Surgical delivered a robust Q3 2025, with revenue climbing 23% to $2.51 billion, fueled by a 33% spike in systems revenue. While the full year reflected broad adoption, the third quarter specifically highlighted the acceleration of the new da Vinci 5 cycle, with 240 units placed in that period alone. Profitability metrics improved notably during the quarter, as operating income expanded 32% to $760 million. Management actively utilized its balance sheet strength to return capital to shareholders, executing $1.92 billion in share repurchases during Q3 2025.
On the strategic front, Brian E. Miller transitioned to Head of Digital and AI Strategy effective January 1, 2026, signaling a deepened focus on integrating artificial intelligence across the surgical ecosystem. The bull case rests on the accelerating replacement cycle for the da Vinci 5 driving continued double-digit system revenue growth. However, bears note that the stock, trading at 60.8x earnings as of the February 2, 2026 report date, leaves little room for execution errors or persistent tariff-related margin pressure.
What to watch: Margin stabilization during the ongoing da Vinci 5 manufacturing ramp; execution of new AI and digital initiatives.
Rev
$10.06B
FY2025
NI
$2.86B
FY2025
EPS
$8.00
FY2025
OCF
$3.03B
FY2025
Year-over-year comparison from 10-K annual reports
Data from SEC Company Facts
Recent SEC Filings
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 22, 2026)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on January 22, 2026, primarily to furnish a press release detailing its financial results for the quarter ended December 31, 2025. While the full financial details are within the press release (Exhibit 99.1), the filing itself does not contain new operational or financial data beyond referencing this external announcement. Investors should refer to the press release for specific performance metrics, revenue figures, and any forward-looking statements or guidance provided by the company. This filing serves as a notification to the market that the company's fourth-quarter and full-year 2025 financial results are now publicly available. The 8-K format indicates that this information is being disclosed in accordance with regulatory requirements, but the company has stipulated that this information is furnished and not deemed "filed" for purposes of certain securities laws, limiting its incorporation by reference into other SEC filings.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 14, 2026)
Intuitive Surgical, Inc. (ISRG) has filed a Current Report on Form 8-K on January 14, 2026, to announce preliminary, unaudited financial results for the fourth quarter and full year of 2025. The report indicates that a press release (Exhibit 99.1) has been issued detailing these results, along with additional preliminary revenue and procedure information (Exhibit 99.2) that has also been made available on the company's Investor Relations website. Investors should note that this information is preliminary and furnished, not filed, meaning it is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Dec 18, 2025)
Intuitive Surgical, Inc. (ISRG) has announced a leadership transition effective January 1, 2026. Brian E. Miller, Ph.D., will be stepping down as Chief Digital Officer. While this role change might initially suggest a shift in focus, Dr. Miller will remain with the company in a newly created position: Head of Digital and AI Strategy. This move indicates a continued commitment to advancing the company's digital and artificial intelligence initiatives, albeit with a restructured reporting line.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 21, 2025)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on October 21, 2025, to announce its financial results for the quarter ended September 30, 2025. The primary purpose of this filing is to furnish a press release containing these results, which was issued on the same date. Investors should refer to the attached press release (Exhibit 99.1) for detailed financial performance and operational updates for the period. While the 8-K itself does not contain the specific financial figures, it serves as the official notification that these results are now public. The company has provided standard disclosures regarding the informational status of this filing, clarifying that it is furnished and not deemed "filed" under Section 18 of the Exchange Act. This means the information is for disclosure purposes and does not carry the same legal implications as a formally filed document in that regard.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 22, 2025)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on July 22, 2025, to announce its financial results for the quarter ended June 30, 2025. The primary purpose of this filing is to furnish a press release that details the company's performance and financial condition for the period. Investors should refer to the press release (Exhibit 99.1) for specific details regarding revenue, profitability, procedure volumes, and any forward-looking statements or guidance provided by the company. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification mechanism for the release of this information. The furnished press release is the key document for understanding ISRG's operational and financial results for the second quarter of 2025, offering insights into the continued adoption and utilization of their robotic surgical systems. Investors are encouraged to review the full press release for a comprehensive understanding.
View all 8-K filings →